In systemic lupus erythematosus (SLE), RFX1 downregulated IL17A, CD70, and CD11a expression by recruiting DNMT1, HDAC1, and SUV39H1 to alter epigenetic modifications in CD4+ T cells from patients with lupus [28, 44]. Here, SUV39H1 is linked to systemic lupus erythematosus.